Transgene Biotek informs about outcome of board meeting

07 May 2025 Evaluate

With reference to letter dated April 26, 2025, Transgene Biotek has informed that the Board of Directors of the Company at their meeting held on May 07, 2025 have resolved as follows: Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed herewith the following: a) Audited Financial Results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended March 31, 2025. b) Report of the Auditors on the Audited Financial Results, both for Standalone and Consolidated financial statements for the financial year ended March 31, 2025. c) Declaration pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Consolidated and Standalone Financial Statements for the Financial Year ended March 31, 2025. The meeting of the Board of Directors of the Company commenced at 11.00 am and concluded at 03.30 pm.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.08 0.08 (2.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×